{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:38:47Z","timestamp":1788565127365,"version":"build-2803163510"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ncl.2024.12.004","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T08:08:40Z","timestamp":1737533320000},"page":"209-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prodromal Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Iro","family":"Boura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Poplawska-Domaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Limbachiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Batzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kallol Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neurol.2012.07.004","article-title":"When does Parkinson's disease begin? From prodromal disease to motor signs","volume":"168","author":"Meissner","year":"2012","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes - key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"105327","DOI":"10.1016\/j.neuint.2022.105327","article-title":"Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics","volume":"156","author":"Yadav","year":"2022","journal-title":"Neurochem Int"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(19)30140-1","article-title":"Serotonergic pathology and disease burden in the premotor and motor phase of A53T \u03b1-synuclein parkinsonism: a cross-sectional study","volume":"18","author":"Wilson","year":"2019","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","article-title":"The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study","volume":"17","author":"Liu","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s13311-020-00894-7","article-title":"Therapy of Parkinson's disease subtypes","volume":"17","author":"Marras","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib10","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/mds.28636","article-title":"Onset of skin, gut, and genitourinary prodromal Parkinson's disease: a study of 1.5 million veterans","volume":"36","author":"Scott","year":"2021","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/ene.13919","article-title":"Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease","volume":"26","author":"Durcan","year":"2019","journal-title":"Eur J Neurol"},{"issue":"Suppl 3","key":"10.1016\/j.ncl.2024.12.004_bib13","first-page":"Iii\/1","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J\u00a0Neurol"},{"issue":"13","key":"10.1016\/j.ncl.2024.12.004_bib14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"},{"issue":"s2","key":"10.1016\/j.ncl.2024.12.004_bib15","first-page":"S281","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib16","first-page":"363","article-title":"The body, the brain, the environment, and Parkinson's disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"e2431949","DOI":"10.1001\/jamanetworkopen.2024.31949","article-title":"Upper gastrointestinal mucosal damage and subsequent risk of Parkinson disease","volume":"7","author":"Chang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib19","first-page":"455","article-title":"The \u03b1-synuclein origin and connectome model (SOC model) of Parkinson's disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib20","doi-asserted-by":"crossref","first-page":"e200162","DOI":"10.1212\/CPJ.0000000000200162","article-title":"Conversion rate of essential tremor to essential tremor Parkinson disease","volume":"13","author":"Louis","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.ncl.2024.12.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107128","article-title":"Essential tremor as a prodromal feature of Parkinson's disease","author":"Yilmaz","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-023-00496-y","article-title":"Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson's disease","volume":"9","author":"Alvarez Jerez","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-020-00914-9","article-title":"Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series","volume":"8","author":"Geut","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson's disease","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.26912","article-title":"Accumulation of lewy-related pathology starts in middle age: the tampere sudden death study","volume":"95","author":"Kok","year":"2024","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","article-title":"Physical frailty, genetic predisposition, and incident Parkinson disease","volume":"80","author":"Zheng","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.10.007","article-title":"Diagnostic value of \u03b1-synuclein seeding amplification assays in \u03b1-synucleinopathies: a systematic review and meta-analysis","volume":"104","author":"Yoo","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A\u00a0biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib32","first-page":"297","article-title":"Proposal for a biologic staging system of Parkinson's disease","volume":"13","author":"Chahine","year":"2023","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A\u00a0biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0000000000200878","article-title":"\u03b1-Synuclein seed amplification assays for diagnosing synucleinopathies: the way forward","volume":"99","author":"Bellomo","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2024.2054","article-title":"Tapping the brakes on new Parkinson disease biological staging","volume":"81","author":"Okubadejo","year":"2024","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib36","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson's disease in primary care: a case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12966-024-01568-9","article-title":"Physical activity and sleep pattern in relation to incident Parkinson's disease: a cohort study","volume":"21","author":"Chen","year":"2024","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib39","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/brain\/awz113","article-title":"Sleep and risk of parkinsonism and Parkinson's disease: a population-based study","volume":"142","author":"Lysen","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa294","article-title":"Prevalence of idiopathic REM behavior disorder: a systematic review and meta-analysis","volume":"44","author":"Cicero","year":"2021","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"H\u00f6gl","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/NSS.S375098","article-title":"Excessive daytime sleepiness in Parkinson's disease","volume":"14","author":"Liu","year":"2022","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.ncl.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.parkreldis.2019.05.013","article-title":"Heterogeneity in progression of prodromal features in Parkinson's disease","volume":"64","author":"Schrag","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.27616","article-title":"Predicting diagnosis of Parkinson's disease: a risk algorithm based on primary care presentations","volume":"34","author":"Schrag","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"3753786","DOI":"10.1155\/2019\/3753786","article-title":"Hyposmia as a predictive marker of Parkinson's disease: a systematic review and meta-analysis","volume":"2019","author":"Sui","year":"2019","journal-title":"BioMed Res Int"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib47","first-page":"3673","article-title":"Prodromal Parkinson disease in patients with idiopathic hyposmia","volume":"267","author":"Marrero-Gonz\u00e1lez","year":"2020","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2022.09.007","article-title":"Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study","volume":"104","author":"Vaswani","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000538515","article-title":"Predictors of the rapid progression in prodromal Parkinson's disease: a longitudinal follow-up study","volume":"70","author":"Liu","year":"2024","journal-title":"Gerontology"},{"key":"10.1016\/j.ncl.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"106115","DOI":"10.1016\/j.nbd.2023.106115","article-title":"Mood disturbances in Parkinson's disease: from prodromal origins to application of animal models","volume":"181","author":"Hayley","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"issue":"24","key":"10.1016\/j.ncl.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson disease: a nationwide cohort study","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"issue":"744","key":"10.1016\/j.ncl.2024.12.004_bib53","first-page":"e482","article-title":"Risk of Parkinson's disease in people aged \u226550 years with new-onset anxiety: a retrospective cohort study in UK primary care","volume":"74","author":"Bazo-Alvarez","year":"2024","journal-title":"Br J Gen Pract"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib54","first-page":"545","article-title":"Cognition and other non-motor symptoms in an at-risk cohort for Parkinson's disease defined by REM-sleep behavior disorder and hyposmia","volume":"14","author":"Pauly","year":"2024","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.26373","article-title":"Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings","volume":"31","author":"Chahine","year":"2016","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cns.13766","article-title":"Characterizing mild cognitive impairment in prodromal Parkinson's disease: a community-based study in China","volume":"28","author":"Pan","year":"2022","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib57","first-page":"1237","article-title":"Non-motor features of Parkinson's disease in women","volume":"11","author":"Hughes","year":"2021","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2021-328062","article-title":"Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2022","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2024.12.004_bib59","doi-asserted-by":"crossref","first-page":"105775","DOI":"10.1016\/j.parkreldis.2023.105775","article-title":"Constipation is linked to accelerated cognitive and motor decline in isolated REM sleep behavior disorder","volume":"119","author":"Woo","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"24","key":"10.1016\/j.ncl.2024.12.004_bib60","doi-asserted-by":"crossref","first-page":"e2545","DOI":"10.1212\/WNL.0000000000207883","article-title":"Frequency of orthostatic hypotension in isolated REM sleep behavior disorder","volume":"101","author":"Elliott","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib61","first-page":"1665","article-title":"Early Parkinson's disease phenotypes tailored by personality, behavior, and motor symptoms","volume":"12","author":"Meira","year":"2022","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.ncl.2024.12.004_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2018.01.013","article-title":"Personality and Parkinson's disease: a meta-analysis","volume":"49","author":"Santangelo","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib65","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.26905","article-title":"Towards a global view of Parkinson's disease genetics","volume":"95","author":"Khani","year":"2024","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib66","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","article-title":"Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study","volume":"22","author":"Rizig","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","article-title":"Tau and MAPT genetics in tauopathies and synucleinopathies","volume":"90","author":"Leveille","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"issue":"43","key":"10.1016\/j.ncl.2024.12.004_bib68","doi-asserted-by":"crossref","first-page":"e12884","DOI":"10.1097\/MD.0000000000012884","article-title":"The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: a meta-Analysis of 47 studies","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ncl.2024.12.004_bib69","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fgene.2019.00644","article-title":"Meta-analysis of the effects of the catechol-O-methyltransferase val158\/108Met polymorphism on Parkinson's disease susceptibility and cognitive dysfunction","volume":"10","author":"Tang","year":"2019","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126827","article-title":"Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases","volume":"23","author":"Azman","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib72","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1474-4422(24)00217-5","article-title":"Concerns with the new biological research criteria for synucleinopathy","volume":"23","author":"Ketchum","year":"2024","journal-title":"Lancet Neurol"},{"issue":"18","key":"10.1016\/j.ncl.2024.12.004_bib73","doi-asserted-by":"crossref","first-page":"e1944","DOI":"10.1212\/WNL.0000000000207147","article-title":"Misfolded \u03b1-synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder","volume":"100","author":"Iranzo","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-024-00421-0","article-title":"DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease","volume":"13","author":"Appleton","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.004_bib76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","article-title":"DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease","volume":"3","author":"Pereira","year":"2023","journal-title":"Nat Aging"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib77","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.03.026","article-title":"Urate and the risk of Parkinson's disease in men and women","volume":"52","author":"Cortese","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib79","first-page":"811","article-title":"Serum uric acid as a putative biomarker in prodromal Parkinson's disease: longitudinal data from the PPMI study","volume":"13","author":"Koros","year":"2023","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.25292","article-title":"Plasma urate and risk of Parkinson's disease: a mendelian randomization study","volume":"84","author":"Kobylecki","year":"2018","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.25436","article-title":"Higher urate in LRRK2 mutation carriers resistant to Parkinson disease","volume":"85","author":"Bakshi","year":"2019","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib82","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mds.25441","article-title":"Plasma urate in REM sleep behavior disorder","volume":"28","author":"Uribe-San Mart\u00edn","year":"2013","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib83","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12883-024-03642-y","article-title":"Associations of sleep disorders with serum neurofilament light chain levels in Parkinson's disease","volume":"24","author":"Qi","year":"2024","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib85","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/mds.28026","article-title":"Intraindividual neurofilament dynamics in serum mark the conversion to sporadic Parkinson's disease","volume":"35","author":"Wilke","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.28826","article-title":"Plasma glutathione and prodromal Parkinson's disease probability","volume":"37","author":"Charisis","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib88","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1038\/s41598-023-38782-7","article-title":"Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram","volume":"13","author":"Karabayir","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib89","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.26719","article-title":"Metagenomics of the gut microbiome in Parkinson's disease: prodromal changes","volume":"94","author":"Palacios","year":"2023","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib90","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22245","article-title":"White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study","volume":"69","author":"Scherfler","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx149","article-title":"Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder","volume":"40","author":"Pyatigorskaya","year":"2017","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib92","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-022-02488-3","article-title":"Adaptive structural changes in the motor cortex and white matter in Parkinson's disease","volume":"144","author":"Fu","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib93","doi-asserted-by":"crossref","first-page":"e14728","DOI":"10.1111\/cns.14728","article-title":"Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2\/GBA mutated Parkinson's disease","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib94","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/mds.29499","article-title":"Increased free water in the putamen in idiopathic REM sleep behavior disorder","volume":"38","author":"Zhang","year":"2023","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib95","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.29366","article-title":"Monitoring substantia nigra degeneration using free water imaging across prodromal and clinical Parkinson's disease","volume":"38","author":"Zhou","year":"2023","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.004_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13101398","article-title":"Brain MRI biomarkers in isolated rapid eye movement sleep behavior disorder: where are we? A systematic review","volume":"13","author":"Grimaldi","year":"2023","journal-title":"Brain Sci"},{"issue":"Pt 4","key":"10.1016\/j.ncl.2024.12.004_bib97","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aww006","article-title":"The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder","volume":"139","author":"Ehrminger","year":"2016","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib98","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/brain\/awaa216","article-title":"Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease","volume":"143","author":"Biondetti","year":"2020","journal-title":"Brain"},{"issue":"1130","key":"10.1016\/j.ncl.2024.12.004_bib99","doi-asserted-by":"crossref","first-page":"20210837","DOI":"10.1259\/bjr.20210837","article-title":"Imaging of the nigrostriatal system for evaluating the preclinical phase of Parkinson's disease development: the utility of neuromelanin, diffusion MRI, and DAT-SPECT","volume":"95","author":"Takahashi","year":"2022","journal-title":"Br J Radiol"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.26218","article-title":"High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2\u2217 relaxometry","volume":"30","author":"Pyatigorskaya","year":"2015","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.27929","article-title":"Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder","volume":"35","author":"Sun","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib102","doi-asserted-by":"crossref","first-page":"119454","DOI":"10.1016\/j.neuroimage.2022.119454","article-title":"Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies","volume":"260","author":"Lancione","year":"2022","journal-title":"Neuroimage"},{"issue":"Pt 8","key":"10.1016\/j.ncl.2024.12.004_bib103","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/brain\/aww124","article-title":"Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease","volume":"139","author":"Rolinski","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2024.12.004_bib104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nicl.2017.08.003","article-title":"Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's disease","volume":"16","author":"Dayan","year":"2017","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ncl.2024.12.004_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.09.026","article-title":"Increased functional connectivity in a population at risk of developing Parkinson's disease","volume":"92","author":"Binder","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2019.12.008","article-title":"Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: a prospective population-based study","volume":"70","author":"Mahlknecht","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib107","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","article-title":"Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosis","volume":"29","author":"Schalkamp","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.25548","article-title":"Gait analysis with wearables predicts conversion to Parkinson disease","volume":"86","author":"Del Din","year":"2019","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(20)30115-0","article-title":"Smartphones versus Parkinson's disease: i-PROGNOSIS","volume":"19","author":"Burton","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib110","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1038\/s41598-020-69369-1","article-title":"Screening of Parkinsonian subtle fine-motor impairment from touchscreen typing via deep learning","volume":"10","author":"Iakovakis","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib111","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00702-022-02575-5","article-title":"The use of wearables for the diagnosis and treatment of Parkinson's disease","volume":"130","author":"Reichmann","year":"2023","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-024-01411-0","article-title":"Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline","volume":"16","author":"Winer","year":"2024","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.ncl.2024.12.004_bib113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.parkreldis.2022.01.003","article-title":"Voice characteristics from isolated rapid eye movement sleep behavior disorder to early Parkinson's disease","volume":"95","author":"Jeancolas","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.26085","article-title":"Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease","volume":"90","author":"Rusz","year":"2021","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib115","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/mds.29180","article-title":"Sensitivity of sniffer dogs for a diagnosis of Parkinson's disease: a diagnostic accuracy study","volume":"37","author":"Gao","year":"2022","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib116","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/mds.29724","article-title":"Challenges and future of the international Parkinson and movement disorder society prodromal Parkinson's disease criteria: are we on the right track?","volume":"39","author":"Kulcsarova","year":"2024","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib117","doi-asserted-by":"crossref","first-page":"e209394","DOI":"10.1212\/WNL.0000000000209394","article-title":"Identification of prodromal Parkinson disease: we may Be able to but should we?","volume":"102","author":"Rees","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2024.12.004_bib118","first-page":"7203259","article-title":"Stigma experienced by Parkinson's disease patients: a descriptive review of qualitative studies","volume":"2017","author":"Maffoni","year":"2017","journal-title":"Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/PROM.S15986","article-title":"Patients' and caregivers' experiences of the impact of Parkinson's disease on health status","volume":"2011","author":"Chiong-Rivero","year":"2011","journal-title":"Patient Relat Outcome Meas"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cger.2019.09.007","article-title":"Driving in Parkinson disease","volume":"36","author":"Ranchet","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mdc3.13676","article-title":"Driving impairment in movement disorders","volume":"10","author":"Makhoul","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0891988720988917","article-title":"How do patients with Parkinson's disease approach advance care planning? A UK-based mixed methods study","volume":"35","author":"Churm","year":"2022","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"16","key":"10.1016\/j.ncl.2024.12.004_bib123","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ajmg.a.32422","article-title":"Fear of health insurance loss among individuals at risk for Huntington disease","volume":"146a","author":"Oster","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib124","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.0000000000000153","article-title":"Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet","volume":"82","author":"Arias","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib125","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/sj.ejhg.5201690","article-title":"The emergence of an ethical duty to disclose genetic research results: international perspectives","volume":"14","author":"Knoppers","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jme.2002.001578","article-title":"The right not to know: an autonomy based approach","volume":"30","author":"Andorno","year":"2004","journal-title":"J\u00a0Med Ethics"},{"issue":"10","key":"10.1016\/j.ncl.2024.12.004_bib127","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/mdc3.13870","article-title":"Ethical considerations of unsolicited medical opinion in movement disorders","volume":"10","author":"Ara\u00fajo","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"19","key":"10.1016\/j.ncl.2024.12.004_bib128","doi-asserted-by":"crossref","first-page":"e2037","DOI":"10.1212\/WNL.0000000000009400","article-title":"Patients' views on the ethical challenges of early Parkinson disease detection","volume":"94","author":"Schaeffer","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.29403","article-title":"The views of patients with isolated rapid eye movement sleep behavior disorder on risk disclosure","volume":"38","author":"P\u00e9rez-Carbonell","year":"2023","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamaneurol.2022.4621","article-title":"Functional impairment in individuals with prodromal or unrecognized Parkinson disease","volume":"80","author":"Miller-Patterson","year":"2023","journal-title":"JAMA Neurol"},{"issue":"23","key":"10.1016\/j.ncl.2024.12.004_bib131","doi-asserted-by":"crossref","first-page":"e2448","DOI":"10.1212\/WNL.0000000000009452","article-title":"Fractures in the prodromal period of Parkinson disease","volume":"94","author":"Camacho-Soto","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib132","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/gerona\/glaa191","article-title":"Frailty and prodromal Parkinson's disease: results from the HELIAD study","volume":"76","author":"Ntanasi","year":"2021","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"7 Suppl 1","key":"10.1016\/j.ncl.2024.12.004_bib133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.0000000000200787","article-title":"Lifestyle interventions for the prevention of Parkinson disease: a recipe for action","volume":"99","author":"Janssen Daalen","year":"2022","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.ncl.2024.12.004_bib134","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-022-00286-1","article-title":"Prodromal Parkinson's disease: hype or hope for disease-modification trials?","volume":"11","author":"Mahlknecht","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"6","key":"10.1016\/j.ncl.2024.12.004_bib136","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib137","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737175.2023.2177535","article-title":"How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease?","volume":"23","author":"Lenka","year":"2023","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib138","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00702-022-02498-1","article-title":"Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice","volume":"129","author":"T\u00f6nges","year":"2022","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib139","doi-asserted-by":"crossref","first-page":"e209522","DOI":"10.1212\/WNL.0000000000209522","article-title":"The ethical landscape of prodromal Parkinson disease: considerations for shared decision-making and health equity","volume":"102","author":"Hoy","year":"2024","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jamaneurol.2017.4243","article-title":"When do \u03b1-synucleinopathies start? An epidemiological timeline: a review","volume":"75","author":"Savica","year":"2018","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib141","first-page":"729","article-title":"Parkinson's disease case ascertainment in the sister study: a cohort for environmental health research","volume":"13","author":"Cao","year":"2023","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib142","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10072-018-3629-2","article-title":"Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease","volume":"40","author":"Sanjari Moghaddam","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2024.12.004_bib143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.parkreldis.2021.01.005","article-title":"Towards subgroup-specific risk estimates: a meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's disease","volume":"84","author":"Janssen Daalen","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib144","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fmed.2020.00308","article-title":"Clinical characteristics of COVID-19 patients with gastrointestinal symptoms: an analysis of seven patients in China","volume":"7","author":"Ai","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000520574","article-title":"Identification of prodromal presentations of Parkinson's disease among primary care outpatients in Germany","volume":"56","author":"Bohlken","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib146","first-page":"1067","article-title":"Motor dysfunction as a prodrome of Parkinson's disease","volume":"10","author":"Alarc\u00f3n","year":"2020","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib147","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jnnp-2020-324266","article-title":"Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson's disease: a cross-sectional study","volume":"92","author":"Kazmi","year":"2021","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib148","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaneurol.2017.2248","article-title":"Association between poor cognitive functioning and risk of incident parkinsonism: the rotterdam study","volume":"74","author":"Darweesh","year":"2017","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2024.12.004_bib149","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/mds.27189","article-title":"Cognition and the course of prodromal Parkinson's disease","volume":"32","author":"Weintraub","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib150","first-page":"6303945","article-title":"Erectile dysfunction preceding clinically diagnosed \u03b1-synucleinopathies: a case-control study in olmsted county","volume":"2019","author":"Hasan","year":"2019","journal-title":"Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.ncl.2024.12.004_bib151","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/aje\/kwm246","article-title":"Erectile function and risk of Parkinson's disease","volume":"166","author":"Gao","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib152","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamaneurol.2018.2248","article-title":"Orthostatic hypotension as a prodromal marker of \u03b1-synucleinopathies","volume":"75","author":"Palma","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib153","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/mds.28303","article-title":"Orthostatic hypotension: a prodromal marker of Parkinson's disease?","volume":"36","author":"Dommershuijsen","year":"2021","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib154","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14737175.2020.1752669","article-title":"Identifying and responding to fatigue and apathy in Parkinson's disease: a review of current practice","volume":"20","author":"Lazcano-Ocampo","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ncl.2024.12.004_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101189","article-title":"Association of visual impairment with risk for future Parkinson's disease","volume":"42","author":"Zhu","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib156","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/WCO.0000000000000711","article-title":"Pain in Parkinson's disease: new concepts in pathogenesis and treatment","volume":"32","author":"Rukavina","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2024.12.004_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12070923","article-title":"Apathy in Parkinson's disease: defining the Park apathy subtype","volume":"12","author":"De Waele","year":"2022","journal-title":"Brain Sci"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib158","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","article-title":"Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease","volume":"80","author":"Schrag","year":"2023","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2024.12.004_bib159","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1474-4422(15)00396-8","article-title":"Joy of super smeller: sebum clues for PD diagnostics","volume":"15","author":"Morgan","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2024.12.004_bib160","article-title":"Trained dogs can detect the odour of Parkinson\u2019s Disease","volume":"2023","author":"Rooney","year":"2023","journal-title":"medRxiv"},{"issue":"44","key":"10.1016\/j.ncl.2024.12.004_bib161","doi-asserted-by":"crossref","first-page":"e35551","DOI":"10.1097\/MD.0000000000035551","article-title":"Restless legs syndrome affects sleep in de novo Parkinson's disease patients","volume":"102","author":"Kim","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.ncl.2024.12.004_bib162","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ana.25179","article-title":"Do subjects with minimal motor features have prodromal Parkinson disease?","volume":"83","author":"Chu","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib163","first-page":"261","article-title":"On the emergence of tremor in prodromal Parkinson's disease","volume":"11","author":"Fearon","year":"2021","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.ncl.2024.12.004_bib164","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/mds.27775","article-title":"Evolution and clustering of prodromal parkinsonian features in GBA1 carriers","volume":"34","author":"Mullin","year":"2019","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ncl.2024.12.004_bib165","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1212\/WNL.0000000000010042","article-title":"GBA variants in REM sleep behavior disorder: a multicenter study","volume":"95","author":"Krohn","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2024.12.004_bib166","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ene.13776","article-title":"Patient's perception: shorter and more severe prodromal phase in GBA-associated PD","volume":"26","author":"Zimmermann","year":"2019","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2024.12.004_bib167","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41531-022-00404-w","article-title":"Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort","volume":"8","author":"Simuni","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.ncl.2024.12.004_bib168","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.27974","article-title":"Penetrance of Parkinson's disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score","volume":"35","author":"Iwaki","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2024.12.004_bib169","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2022.03.020","article-title":"Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease","volume":"98","author":"S\u00e1nchez-Rodr\u00edguez","year":"2022","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861924000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861924000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:56:05Z","timestamp":1750762565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861924000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0733861924000999"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2024.12.004","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodromal Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}